光啟技術(002625.SZ):簽訂8785.92萬元的批產合同
格隆匯 12 月 7日丨光啟技術(002625.SZ)公佈,公司於2020年11月5日披露了公司下屬子公司深圳光啟尖端技術有限責任公司(“光啟”)收到了航空結構產品訂貨需求(“訂貨需求”),其中已明確供貨價格的產品總金額超過人民幣12億元,未明確供貨價格的產品總金額將根據雙方價格談判結果及產品的交付需求確定。公司於2020年12月1日披露了公司與客户A簽署了上述需求中一件產品的批產合同,合同總金額為6192萬元。
近日,客户B就上述需求中第二件產品的近期需求與光啟簽訂批產合同,合同總金額為8785.92萬元。
此次簽訂的合同為公司新一代超材料航空結構等產品取得的持續性批量訂單,產品價格已經在訂貨需求中明確,合同金額佔公司2019年度經審計超材料業務營業收入的40.07%,預計對公司2020-2021年度的經營業績產生積極影響。公司將持續增強超材料產品的市場競爭力,進一步提升公司盈利水平。本次簽訂的合同的履行不影響公司業務的獨立性,公司不會因為履行本次合同對相關客户形成依賴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.